The impact of the COVID-19 pandemic on illicit drug supply, drug-related behaviour of people who use drugs and provision of drug related services in Georgia: results of a mixed methods prospective cohort study
- PMID: 35264181
- PMCID: PMC8906357
- DOI: 10.1186/s12954-022-00601-z
The impact of the COVID-19 pandemic on illicit drug supply, drug-related behaviour of people who use drugs and provision of drug related services in Georgia: results of a mixed methods prospective cohort study
Abstract
Background: This study examines the effects of COVID-19 related restrictions on the supply of illicit drugs, drug-use behaviour among people who use drugs (PWUD) regularly (at least weekly), and drug-related service provision in Tbilisi, Georgia.
Methodology: In this mixed methods study, a cohort of 50 Georgian PWUD recruited through a snow-ball sampling participated in a bi-weekly online survey in April-September, 2020. They also took part in the qualitative telephone interviews at 12- and 24-week follow-up time points. In addition, four key informants (field experts) were interviewed monthly to assess their perceptions of changes in the illicit drug market and drug service delivery.
Results: Mean age in the sample was 36 (range 18-60); 39 (78%) were males. Perceived availability of drugs was reduced during the lockdown, and many PWUD switched to alternative substances when preferred drugs were not available. On average, participants used significantly fewer substances over the course of the study, from 3.5 substances in the preceding 14 days to 2.1 (aOR 0.92; 95% CI 0.90-0.94). Consumption of cannabis products declined significantly (aOR 0.89; 95% CI 0.84-0.95), likewise alcohol (aOR 0.94; 95% CI 0.88-1.0), diverted medicinal methadone (aOR 0.85; 95% CI 0.8-0.9) and diverted medicinal buprenorphine (aOR 0.91; 95% CI 0.84-0.99). PWUD cited fewer contacts with drug dealers, the lack of transportation, and the lack of conventional recreational environment as the main reasons for these changes. When access to sterile injection equipment was limited, PWUD exercised risk-containing injection behaviours, such as buying drugs in pre-filled syringes (aOR 0.88; 95% CI 0.80-0.96). Harm reduction and treatment programs managed to adopt flexible strategies to recover services that were affected during the initial stage of the pandemic.
Conclusions: COVID-19-related restrictive measures mediated specific changes in supply models and drug-use behaviours. While adjusting to the new environment, many PWUD would engage in activities that put them under increased risk of overdose and blood-borne infections. Harm reduction and treatment services need to develop and implement protocols for ensuring uninterrupted service delivery during lockdowns, in anticipation of the similar epidemics or other emergency situations.
Keywords: COVID-19; Drug-use behaviour; Georgia; Illicit drug supply.
© 2022. The Author(s).
Conflict of interest statement
The authors declared that they have no conflict of interest.
Figures



Similar articles
-
Substance use during the COVID-19 pandemic: What is really happening?Psychiatriki. 2022 Mar 28;33(1):17-20. doi: 10.22365/jpsych.2022.072. Epub 2022 Feb 21. Psychiatriki. 2022. PMID: 35255473 English, Greek, Modern.
-
Changes in substance supply and use characteristics among people who use drugs (PWUD) during the COVID-19 global pandemic: A national qualitative assessment in Canada.Int J Drug Policy. 2021 Jul;93:103237. doi: 10.1016/j.drugpo.2021.103237. Epub 2021 Apr 20. Int J Drug Policy. 2021. PMID: 33893026 Free PMC article.
-
Negative changes in illicit drug supply during COVID-19: Associations with use of overdose prevention and health services among women sex workers who use drugs (2020-2021).Int J Drug Policy. 2023 Nov;121:104212. doi: 10.1016/j.drugpo.2023.104212. Epub 2023 Oct 3. Int J Drug Policy. 2023. PMID: 37797570 Free PMC article.
-
Health service utilisation and access for people who inject drugs during COVID-19.Drug Alcohol Rev. 2022 Sep;41(6):1304-1310. doi: 10.1111/dar.13456. Epub 2022 Mar 9. Drug Alcohol Rev. 2022. PMID: 35266229 Free PMC article. Review.
-
The Impact of the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Pandemic on Substance Use in the United States.Clin Infect Dis. 2022 Aug 15;75(Suppl 1):S81-S85. doi: 10.1093/cid/ciac311. Clin Infect Dis. 2022. PMID: 35476024 Free PMC article. Review.
Cited by
-
Negotiating an Illicit Economy in the Time of COVID-19: Selling and Buying Dilemmas in the Lives of People Who Use Drugs in Scotland.Contemp Drug Probl. 2022 Dec;49(4):369-384. doi: 10.1177/00914509221122704. Epub 2022 Sep 8. Contemp Drug Probl. 2022. PMID: 36312792 Free PMC article.
-
Sleep, psychological symptoms, and cannabis use before, during, and after COVID-19 "stay-at-home" orders: a structural equation modeling approach.J Cannabis Res. 2025 Mar 24;7(1):18. doi: 10.1186/s42238-025-00269-9. J Cannabis Res. 2025. PMID: 40128821 Free PMC article.
-
What impact did the COVID-19 pandemic have on the variability of fentanyl concentrations in the Vancouver, Canada illicit drug supply? An interrupted time-series analysis.BMJ Public Health. 2023 Oct 12;1(1):e000197. doi: 10.1136/bmjph-2023-000197. eCollection 2023 Nov. BMJ Public Health. 2023. PMID: 40017876 Free PMC article.
-
Insights into the Experiences of Persons with Substance Use Disorders During COVID-19 Lockdown in Lagos, Nigeria: A Qualitative Investigation.Subst Use. 2024 Dec 17;18:29768357241307752. doi: 10.1177/29768357241307752. eCollection 2024 Jan-Dec. Subst Use. 2024. PMID: 39691942 Free PMC article.
-
Structural and social changes due to the COVID-19 pandemic and their impact on engagement in substance use disorder treatment services: a qualitative study among people with a recent history of injection drug use in Baltimore, Maryland.Harm Reduct J. 2024 May 8;21(1):91. doi: 10.1186/s12954-024-01008-8. Harm Reduct J. 2024. PMID: 38720307 Free PMC article.
References
-
- European Monitoring Centre for Drugs and Drug Addiction . Impact of COVID-19 on drug markets, drug use, drug-related harms and responses in east European Neighbourhood Policy countries. EMCDDA: Publications Office of the European Union, Luxembourg; 2020.
-
- European Monitoring Centre for Drugs and Drug Addiction. Impact of COVID-19 on patterns of drug use and drugrelated harms in Europe. Lisbon: EMCDDA; 2020.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous